The propagation of genetic polymorphism in CYP2C9 into warfarin pharmacokinetics: An integrated model

被引：0
|
作者：
Dickinson, GL [1 ]
Lennard, MS [1 ]
Tucker, GT [1 ]
Rostami-Hodjegan, A [1 ]
机构：
[1] Univ Sheffield, Acad Unit Clin Pharmacol, Sheffield, S Yorkshire, England
来源：
DRUG METABOLISM REVIEWS | 2005年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
74
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [21] Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects
    Gardin, Anne
    Ufer, Mike
    Legangneux, Eric
    Rossato, Gianluca
    Jin, Yi
    Su, Zhenzhong
    Pal, Parasar
    Li, Wenkui
    Shakeri-Nejad, Kasra
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 349 - 361
  • [22] Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast
    Hyun-Jee Lee
    Young-Hoon Kim
    Se-Hyung Kim
    Choong-Min Lee
    Ae-Yun Yang
    Choon-Gon Jang
    Seok-Yong Lee
    Jung-Woo Bae
    Chang-Ik Choi
    Archives of Pharmacal Research, 2016, 39 : 1013 - 1019
  • [23] CYP2C9 genetic polymorphism significantly affected the pharmacokinetics of candesartan and its metabolite.
    Byeon, Ji-Yeong
    Park, Jung-In
    Jang, Choon-Gon
    Lee, Seok-Yong
    PHARMACOTHERAPY, 2012, 32 (10): : E234 - E235
  • [24] Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects
    Anne Gardin
    Mike Ufer
    Eric Legangneux
    Gianluca Rossato
    Yi Jin
    Zhenzhong Su
    Parasar Pal
    Wenkui Li
    Kasra Shakeri-Nejad
    Clinical Pharmacokinetics, 2019, 58 : 349 - 361
  • [25] Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data
    Makiko Kusama
    Kazuya Maeda
    Koji Chiba
    Akinori Aoyama
    Yuichi Sugiyama
    Pharmaceutical Research, 2009, 26
  • [26] Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data
    Kusama, Makiko
    Maeda, Kazuya
    Chiba, Koji
    Aoyama, Akinori
    Sugiyama, Yuichi
    PHARMACEUTICAL RESEARCH, 2009, 26 (04) : 822 - 835
  • [27] Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast
    Lee, Hyun-Jee
    Kim, Young-Hoon
    Kim, Se-Hyung
    Lee, Choong-Min
    Yang, Ae-Yun
    Jang, Choon-Gon
    Lee, Seok-Yong
    Bae, Jung-Woo
    Choi, Chang-Ik
    ARCHIVES OF PHARMACAL RESEARCH, 2016, 39 (07) : 1013 - 1019
  • [28] Warfarin Dose Adjustments Based on CYP2C9 Genetic Polymorphisms
    Mark W. Linder
    Stephen Looney
    Jesse E. Adams
    Nancy Johnson
    Deborah Antonino-Green
    Nichole Lacefield
    Bonny L. Bukaveckas
    Roland Valdes
    Journal of Thrombosis and Thrombolysis, 2002, 14 : 227 - 232
  • [29] Impact of CYP2C9 genetic polymorphism on warfarin sensitivity among acutely ill patients.
    Muszkat, M
    Krasilnikov, I
    Caraco, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P57 - P57
  • [30] Genetic analysis of CYP2C9 polymorphism in a Japanese population
    Nasu, K
    Kubota, T
    Ishizaki, T
    PHARMACOGENETICS, 1997, 7 (05): : 405 - 409
12345